Radioligand therapy (RLT) is no longer a niche therapy but is now a mainstream treatment option and included in National Comprehensive Cancer Network (NCCN) guidelines for certain cancers. Dr. Mike ...
MELBOURNE, Australia and INDIANAPOLIS, June 23, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that the United States (U.S.) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results